0001354488-13-006714.txt : 20131204 0001354488-13-006714.hdr.sgml : 20131204 20131204165552 ACCESSION NUMBER: 0001354488-13-006714 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131202 FILED AS OF DATE: 20131204 DATE AS OF CHANGE: 20131204 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PERNIX THERAPEUTICS HOLDINGS, INC. CENTRAL INDEX KEY: 0001024126 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330724736 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 33219 FOREST WEST STREET CITY: MAGNOLIA STATE: TX ZIP: 77354 BUSINESS PHONE: (832) 934-1825 MAIL ADDRESS: STREET 1: 33219 FOREST WEST STREET CITY: MAGNOLIA STATE: TX ZIP: 77354 FORMER COMPANY: FORMER CONFORMED NAME: GOLF TRUST OF AMERICA INC DATE OF NAME CHANGE: 19961002 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Collins Cooper C. CENTRAL INDEX KEY: 0001485508 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14494 FILM NUMBER: 131257855 MAIL ADDRESS: STREET 1: 33219 FOREST WEST DRIVE CITY: MAGNOLIA STATE: TX ZIP: 77354 4 1 issuerdirect_section16.xml PRIMARY DOCUMENT X0306 4 2013-12-02 0 0001024126 PERNIX THERAPEUTICS HOLDINGS, INC. PTX 0001485508 Collins Cooper C. 33219 FOREST WEST DR MAGNOLIA TX 77354 1 1 1 Chief Strategic Officer Common Stock 2013-12-02 4 S 0 14100 2.5454 D 6435946 D Common Stock 2013-12-03 4 S 0 7429 2.4798 D 6428517 D Common Stock 2013-12-04 4 S 0 31019 2.3824 D 6397498 D Common Stock 245163 I Spouse Common Stock 390681 I GRAT Common Stock 390681 I Spousal GRAT The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/26/13. The price reported in Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.50 to $2.67, inclusive. The reporting person undertakes to provide to Pernix Therapeutics Holdings, Inc., any security holder of Pernix Therapeutics Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $2.56, inclusive. The reporting person undertakes to provide to Pernix Therapeutics Holdings, Inc., any security holder of Pernix Therapeutics Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.32 to $2.50, inclusive. The reporting person undertakes to provide to Pernix Therapeutics Holdings, Inc., any security holder of Pernix Therapeutics Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/Cooper C. Collins 2013-12-04